SFCED | San Francisco Center for Economic Development


Will Boston And San Francisco Continue To Dominate Biotech Innovation?

When you look at the investment capital deployed toward Biotech start-ups in Boston and San Francisco, you might wonder what these two cities are doing to capture nearly half the invested venture capital available in 2013, while other cities lag far behind. We note that according to the National Venture Capital Association and Thomson Reuter’s research, these two cities captured 47 % of all invested biotech capital, and also led in the number of deals financed.

San Francisco edged out Boston in total invested capital in 2013, $1.15 Billion to $933 million, however Boston led in the previous two years. The two cities have battled back and forth for the top spot in recent years, and if you are one of the other 15 cities cited in the NVCA report, you’ve got a high mountain to climb to challenge these top contenders. San Diego comes in third with $387 million invested capital and the slide south is pretty steep from there.  Washington, D.C, comes in fourth with all its federal life science grants, followed by Oakland California. It’s very revealing to learn that three of the top five cities are in California. While New York City comes in a distant seventh.

Read more: Forbes.com Will Boston And San Francisco Continue To